Antitrypsin Deficiency, known as AATD, is an inherited condition passed from parents to their children through their genes.
The deficiency will result in serious lung disease in adults and, at times, can also cause lung disease in young adults.
AATD is commonly misdiagnosed as chronic asthma or COPD. In fact, out of the 12 million patients diagnosed with COPD in America, approximately 1 to 3 percent likely have A1AD.
Left untreated, A1AD results in progressive destruction of lung tissue resulting in severe loss of lung function and life expectancy.
Laird Ozmon of Ozmon Law in Joliet has pioneered the fight to seek fair compensation for those patients who have been misdiagnosed and have suffered such serious lung damage.
AATD cannot be diagnosed by symptoms or by a medical examination alone; you need to get a simple, reliable blood test to know for sure.
When AATD relates to the lungs, individuals experience shortness of breath – especially at rest, wheezing, chronic bronchitis, reoccurring chest colds, year-round allergies or early onset of emphysema.
When AATD relates to the liver, individuals experience unexplained liver disease or elevated liver enzymes. They may have jaundice or swelling of the abdomen or legs.
Required treatment involves serum replacement of this protein, which then provides this protective coating. However, lost lung function cannot be restored and most misdiagnosed patients ultimately must undergo lung transplants to extend life expectancy.
Laird Ozmon has a proven track record of obtaining high dollar value settlements and jury verdicts involving personal injury law and Alpha-1 Antitrypsin Deficiency (AATD) cases, including one of the first and highest settlements for an Alpha-1 patient for $8 Million dollars.
While Ozmon Law is handling your case, Laird will always try to negotiate a fair settlement on your behalf. However, if a fair settlement cannot be negotiated, Laird’s 30 years of trial experience will work for you in attempting to recover maximum compensation from the jury.